Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

QB3@953 Rebranded As MBC BioLabs in San Carlos and San Francisco, California

02/06/2018
QB3@953 will become MBC BioLabs with the addition of a brand-new facility in San Carlos, California. The facility is situated near San Mateo on the San Francisco Peninsula, 24 miles south of San Francisco and 26 miles north of San Jose.

QB3@953, an independent provider of innovative shared laboratory space located at 953 Indiana St. in San Francisco, was born out of the California Institute for Quantitative Biosciences, a three-campus organization at UC San Francisco, Berkeley, and Santa Cruz.

MBC BioLabs said it provides space as small as a single bench in fully-equipped labs. Scientists can conduct experiments on their first day, cutting months and millions of dollars off the time and cost necessary to gather data.

According to company officials, MBC BioLabs facilities in San Francisco and San Carlos is home to 45 energetic young companies. Since opening its doors four years ago, MBC BioLabs tenant companies have raised over $1.7 billion dollars.

With the addition of a new purpose-built life-science incubator at 733 Industrial Rd. in San Carlos, the QB3@953 name is being updated to encompass the multiple Bay Area locations, affiliation with the national BioLabs alliance, and association with Mission Bay Capital, company officials said.

"We are excited to be adding more premier laboratory space to further 'enable awesome.' We love helping entrepreneurial life-scientists efficiently build innovative companies, but we simply haven't had enough space. We have only been able to accept 10% of our applicants," said MBC BioLab's General Manager, Doug Crawford. "While it is difficult to part with the cherished QB3@953 name, MBC BioLabs better-captures our expanding reach."

The 953 Indiana St. facility houses 45 companies in only 24,000 square feet. By providing full laboratory services and incremental space as needed, companies grow efficiently using just the capital and resources necessary. The first San Carlos expansion phase will add an additional 10,000 square feet to the MBC BioLabs network in Q1 2018, accommodating 15-20 new companies. With the addition of another 25,000 square feet in San Carlos by Q2 2019, over 100 companies will be part of the MBC BioLabs community.

MBC BioLabs said it enjoys the strong support of a growing community of pharmaceutical partners. Our Platinum Sponsors Amgen, GSK, Pfizer and our newest partner, AbbVie, are a vital part of enabling MBC BioLabs to fulfill its mission of efficiently bringing together the smallest and largest companies to drive innovative patient treatments and cures.

Article Discussion

Share